IL10 and necrotizing enterocolitis: However, in rat models, Yan et al. found that BCFAs could reduce the incidence of necrotizing enterocolitis, increase the content of IL-10 in intestinal anti-inflammatory cells, and change the microbial ecology of the gastrointestinal tract [37].